The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by Nω-nitro-L-arginine methyl ester

Hypertension

Volumn 30, Issue 1, 1997, Pages 64-70

  Sander, Mikael ^a   Hansen, Jim ^a   Victor, Ronald G ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Endothelin; L NAME; Nitric oxide; Sympathectomy; Sympathetic nervous system

Indexed keywords

NITRIC OXIDE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL INNERVATION; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SYMPATHECTOMY;

EID: 0030802281     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.64     Document Type: Article

References (81)

1. Johnson RA, Freeman RH. Sustained hypertension in the rat induced by chronic blockade of nitric oxide production. Am J Hypertens. 1992;5:919-922.
2. Ward JE, Angus JA. Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: role of nitric oxide in the control of vascular tone. J Cardiovasc Pharmacol. 1993;21:804-814.
3. Manning R Jr, Hu L, Mizelle HL, Montani JP, Norton MW. Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension. 1993;22:40-48.
4. Hu L, Manning R Jr, Brands MW. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension. 1994;23:185-194.
5. G-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent presser agent in the guinea: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun. 1989;160:881-886.
6. Fernandez N, Garcia JL, Garcia-Villalon AL, Monge L, Gomez B, Dieguez G. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats. Br J Pharmacol. 1993;110:428-434.
7. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
8. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2: 997-1000.
9. Shapoval LN, Sagach VF, Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett. 1991;132:47-50.
10. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res. 1992; 70:607-611.
11. Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther. 1992;262:343-347.
12. Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res. 1993;72:511-516.
13. Iadecola C, Faris PL, Hartman BK, Xu X. Localization of NADPH diaphorase in neurons of the rostral ventral medulla: possible role of nitric oxide in central autonomie regulation and oxygen chemoreception. Brain Res. 1993;603:173-179.
14. Tagawa T, Imaizumi T, Harada S, Endo T, Shiramoto M, Hirooka Y, Takeshita A. Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brainstem slices. Circ Res. 1994;75: 70-76.
15. Zanzinger J, Czachurski J, Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am J Physiol. 1995;268:R958-R962.
16. el Karib AO, Sheng J, Betz AL, Malvin RL. The central effects of a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine) on blood pressure and plasma renin. Clin Exp Hypertens. 1993;15: 819-832.
17. Okamoto H, Hoka S, Kawasaki T, Okuyama T, Takahashi S. L-arginine attenuates ketamine-induced increase in renal sympathetic nerve activity. Anesthesiology. 1994;81:137-146.
18. Ma S, Abboud FM, Felder RB. Effects of L-arginine-derived nitric oxide synthesis on neuronal activity in nucleus tractus solitarius. Am J Physiol. 1995;268:R487-R491.
19. Zhang Z-Q, Barrés C, Julien C. Nitric oxide synthesis and the control of blood pressure in sympathectomized rats. Genet Hypertens. 1992;218:27-29.
20. G-nitro-L-arginine on autonomic nerve activity. Br J Pharmacol. 1991;103:2004-2008.
21. Manning RD Jr, Hu L, Williamson TD. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition. Hypertension. 1994;23(part 2):951-956.
22. G-monomethyl-L-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats [see comments]. Am J Physiol. 1992;262:R1137-R1144.
23. G-nitro-L-arginine methyl ester. Br J Pharmacol. 1990;101: 632-639.
24. Minami N, Imai Y, Hashimoto J, Abe K. Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin Sci. 1995;89:177-182.
25. Ingles AC, Ruiz FJ, Salom MG, Quesada T, Carbonell LF. Role of nitric oxide and prostaglandins in the regulation of blood pressure in conscious rats. Can J Physiol Pharmacol. 1995;73:693-698.
26. Sander M, Hansen PG, Victor RG. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension. 1995;26:691-695.
27. Zanchi A, Schaad NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, Waeber B. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol. 1995;268:H2267-H2273.
28. Cunha RS, Cabral AM, Vasquez EC. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am J Hypertens. 1993;6:806-809.
29. Johnson E Jr, O'Brien F, Werbitt R. Modification and characterization of the permanent sympathectomy produced by the administration of guanethidine to newborn rats. Eur J Pharmacol. 1976; 37:45-54.
30. Kidd GJ, Heath JW, Dunkley PR. Degeneration of myelinated sympathetic nerve fibers following treatment with guanethidine. J Neurocytol. 1986;15:561-572.
31. Lee RM, Triggle CR, Cheung DW, Coughlin MD. Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension. 1987;10: 328-338.
32. Schmidt RE, Summerfield AL, Hickey WF. Ultrastructural and immunohistologic characterization of guanethidine-induced destruction of peripheral sympathetic neurons. J Neuropathol Exp Neurol. 1990;49:150-167.
33. Kumagai H, Averill DB, Khosla MC, Ferrario CM. Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats. Hypertension. 1993;21: 476-484.
34. Hansen J, Jacobsen TN, Victor RG. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension. 1994;24:439-444.
35. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension. 1994;23(part 2):971-975.
36. Castellano M, Rizzoni D, Beschi M, Muiesan ML, Porteri E, Bettoni G, Salvetti M, Cinelli A, Zulli R, Agabiti-Rosei E. Relationship between sympathetic nervous system activity, baroreftex and cardiovascular effects after acute nitric oxide synthesis inhibition in humans. J Hypertens. 1995;13:1153-1161.
37. Traystman RJ, Moore LE, Helfaer MA, Davis S, Banasiak K, Williams M, Hurn PD. Nitro-L-arginine analogues: dose- and time-related nitric oxide synthase inhibition in brain. Stroke. 1995;26: 864-869.
38. Salter M, Duffy C, Garthwaite J, Strijbos PJ. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of N-omega-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacology. 1995;34:639-649.
39. Salter M, Duffy C, Hazelwood R. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results. Neuropharmacology. 1995;34: 327-334.
40. Iadecola C, Xu X, Zhang F, Hu J, el-Fakahany EE. Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res. 1994;19:501-505.
41. 3H]arginine in cultured neurons: characteristics and inhibition by nitric oxide synthase inhibitors. J Neurochem. 1993;61:364-367.
42. 3H]arginine transport and nitric oxide synthase in rat brain synaptosomes. Neurosci Lett. 1994;181:1-4.
43. Stuhlmiller DFE, Boje KMK. Characterization of L-arginine and aminoguanidine uptake into isolated rat choroid plexus: differences in uptake mechanisms and inhibition by nitric oxide synthase inhibitors. J Neurochem. 1995;65:68-74.
44. Hirai T, Musch TI, Morgan DA, Kregel KC, Claassen DE, Pickar JG, Lewis SJ, Kenney MJ. Differential sympathetic nerve responses to nitric oxide inhibition in anesthetized rats. Am J Physiol. 1995; 269:R807-R813.
45. Jover B, Herizi A, Ventre F, Dupont M, Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension. 1993;21(part 2):944-948.
46. G-nitro-L-arginine induces sustained hypertension in normotensive Wistar-Kyoto rats. Clin Exp Pharmacol Physiol. 1992;19:583-586.
47. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
48. Baylis C. Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
49. Krukoff TL, Gehlen F, Ganten D, Wagner J. Gene expression of brain nitric oxide synthase and soluble guanylyl cyclase in hypothalamus and medulla of two-kidney, one clip hypertensive rats. Hypertension. 1995;26:171-176.
50. Hökfelt T, Ceccatelli S, Gustafsson L, Hulling A-L, Verge V, Villar M, Xu X-J, Xu Z-Q, Wiesenfeld-Hallin Z, Zhang X. Plasticity of NO synthase expression in the nervous and endocrine systems. Neuropharmacology. 1994;33:1221-1227. Review.
51. Ruda MA, Besse D, Inagaki S, DeLeon M, Ren K. Nitric oxide expression and regulation in the dorsal root ganglion and spinal cord. Ann N Y Acad Sci. 1994;738:181-190.
52. G-nitro-L-arginine methyl ester treatment in conscious rats. Hypertension. 1994;23(part 2):982-986.
53. Lantelme P, Lo M, Sassard J. Decreased cardiac baroreflex sensitivity is not due to cardiac hypertrophy in NG-nitro-L-arginine methyl ester-induced hypertension. J Hypertens. 1994;12:791-795.
54. Du ZY, Dusting GJ, Woodman OL. Baroreceptor reflexes and vascular reactivity during inhibition of nitric oxide synthesis in conscious rabbits. Eur J Pharmacol. 1992;214:21-26.
55. Vasquez EC, Cunha RS, Cabrai AM. Baroreceptor reflex function in rats submitted to chronic inhibition of nitric oxide synthesis. Braz J Med Biol Res. 1994;27:767-774.
56. Liu JL, Murakami H, Zucker IH. Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits. Am J Physiol. 1996;270:R1361-R1370.
57. Hohler B, Mayer B, Kummer W. Nitric oxide synthase in the rat carotid body and carotid sinus. Cell Tissue Res. 1994;276:559-564.
58. Aimi Y, Fujimura M, Vincent SR, Kimura H. Localization of NADPH-diaphorase-containing neurons in sensory ganglia of the rat. J Comp Neurol. 1991;306:382-392.
59. Terenghi G, Riveros-Moreno V, Hudson LD, Ibrahim NB, Polak JM. Immunohistochemistry of nitric oxide synthase demonstrates immunoreactive neurons in spinal cord and dorsal root ganglia of man and rat. J Neurol Sci. 1993;118:34-37.
60. Vizzard MA, Erdman SL, Roppolo JR, Forstermann U, de Groat WC. Differential localization of neuronal nitric oxide synthase immunoreactivity and NADPH-diaphorase activity in the cat spinal cord. Cell Tissue Res. 1994;278:299-309.
61. Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 1992;46:755-784.
62. Lu Y, Ding YQ, Qin BZ, Li JS. The distribution and origin of axon terminals with NADPH diaphorase activity in the nucleus of the solitary tract of the rat. Neurosci Lett. 1994;171:70-72.
63. Dun NJ, Dun SL, Forstermann U, Tseng LF. Nitric oxide synthase immunoreactivity in rat spinal cord. Neurosci Lett. 1992;147: 217-220.
64. Anderson CR, Edwards SL, Furness JB, Bredt DS, Snyder SH. The distribution of nitric oxide synthase-containing autonomic preganglionic terminals in the rat. Brain Res. 1993;614:78-85.
65. Greenberg SS, Diecke FP, Peevy K, Tanaka TP. Release of norepinephrine from adrenergic nerve endings of blood vessels is modulated by endothelium-derived relaxing factor. Am J Hypertens. 1990;3:211-218.
66. Springall DR, Riveros-Moreno V, Buttery L, Suburo A, Bishop AE, Merrett M, Moncada S, Polak JM. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous anti-bodies suggesting different isoforms. Histochemistry. 1992;98: 259-266.
67. Cohen AS, Weinreich D, Kao JP. Nitric oxide regulates spike frequency accommodation in nodose neurons of the rabbit. Neurosci Lett. 1994;173:17-20.
68. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno V, Martinez-Murillo R, Polak JM, Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B Biol Sci. 1994;345:175-221.
69. Lumme A, Vantahalo S, Soinila S. Axonal transport of nitric oxide synthase in autonomic nerves. J Auton Nerv Syst. 1996;56:207-214.
70. G-nitro-L-arginine on sympathetic and parasympathetic vascular control in vivo. Neuroscience. 1994;62:189-203.
71. Sheng H, Hughes ML, Murad F, Briggs CA. Evidence that nitric oxide mediates the cyclic GMP response to synaptic activity in the rat superior cervical ganglion. Brain Res. 1992;597:343-345.
72. Hakim MA, Hirooka Y, Coleman MJ, Bennett MR, Dampney RA. Evidence for a critical role of nitric oxide in the tonic excitation of rabbit renal sympathetic preganglionic neurones. J Physiol. 1995; 482:401-407.
73. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension [see comments]. N Engl J Med. 1990;323:22-27.
74. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
75. Treasure CB, Manoukian SV, Klein JL, Vita JA, Nabel EG, Renwick GH, Selwyn AP, Alexander RW, Ganz P. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 1992;71:776-781.
76. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
77. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension. 1989;14:177-183.
78. Floras JS, Hara K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens. 1993;11:647-655.
79. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension. 1989;13(part 2):870-877.
80. Matsukawa T, Mano T, Gotoh E, Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest. 1993;92:25-28.
81. Converse R Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918.